Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate ProKidney Corp. before investing.

In this article, we go over a few key elements for understanding ProKidney Corp.’s stock price such as:

• ProKidney Corp.’s current stock price and volume
• Why ProKidney Corp.’s stock price changed recently
• Upgrades and downgrades for PROK from analysts
• PROK’s stock price momentum as measured by its relative strength

About ProKidney Corp. (PROK)

Before we jump into ProKidney Corp.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Want to learn more about ProKidney Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about ProKidney Corp..

ProKidney Corp.’s Stock Price as of Market Close

As of April 28, 2025, 12:29 PM, CST, ProKidney Corp.’s stock price was $0.981.

ProKidney Corp. is down 3.82% from its previous closing price of $1.020.

During the last market session, ProKidney Corp.’s stock traded between $0.935 and $1.050. Currently, there are approximately 128.21 million shares outstanding for ProKidney Corp..

ProKidney Corp.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

ProKidney Corp. Stock Price History

ProKidney Corp.’s (PROK) price is currently up 11.96% so far this month.

During the month of April, ProKidney Corp.’s stock price has reached a high of $1.180 and a low of $0.460.

Over the last year, ProKidney Corp. has hit prices as high as $4.440 and as low as $0.460. Year to date, ProKidney Corp.’s stock is down 41.95%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused ProKidney Corp. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 25, 2025, there were analysts who downgraded ProKidney Corp.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate ProKidney Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on ProKidney Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about ProKidney Corp. (PROK) by visiting AAII Stock Evaluator.

Relative Price Strength of ProKidney Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 25, 2025, ProKidney Corp. has a weighted four-quarter relative price strength of -24.50%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how ProKidney Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

ProKidney Corp. Stock Price: Bottom Line

As of April 28, 2025, ProKidney Corp.’s stock price is $0.981, which is down 3.82% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like ProKidney Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.